...
首页> 外文期刊>Urology >Retroperitoneoscopic nephroureterectomy for transitional cell carcinoma of the renal pelvis and ureter: Nagoya experience.
【24h】

Retroperitoneoscopic nephroureterectomy for transitional cell carcinoma of the renal pelvis and ureter: Nagoya experience.

机译:腹腔镜肾结直肠癌切除术治疗肾盂和输尿管移行细胞癌:名古屋的经验。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To evaluate the efficacy of our new retroperitoneoscopic nephroureterectomy for patients with transitional cell carcinoma of the renal pelvis and ureter, we present the operative procedure and analysis of the clinical outcome of retroperitoneoscopy in 23 patients. METHODS: Twenty-three patients with transitional cell carcinoma of the upper urinary tract underwent retroperitoneal laparoscopic nephroureterectomy between February 2000 and February 2002. Patient age ranged from 44 to 83 years (mean 66.7). Each kidney was retroperitoneoscopically dissected en bloc, together with the perirenal fatty tissue, lymph nodes, and/or adrenal gland, without transecting the ureter. The lower ureter was resected with the bladder cuff transected using an ultrasonic scalpel and an endoscopic gastrointestinal automatic stapler. The dissected specimen was removed intact through a 6-cm-long original incision. RESULTS: The mean operating time was 4.8 hours, including 0.7 hours for complete removal of the ureteral end with the bladder cuff. The mean estimated blood loss was 304 mL. The mean time to recovery to normal activity was 18 days. In the mean follow-up period of 15 months, 2 patients died of cancer progression in the sixth postoperative month, 2 died of other causes, and 4 had recurrent transitional cell carcinoma of the bladder after surgery. CONCLUSIONS: Our retroperitoneal laparoscopic nephroureterectomy using an endoscopic gastrointestinal automatic stapler is a fast, low-risk, and minimally invasive procedure and might be an alternative to other laparoscopic techniques and open nephroureterectomy. However, long-term follow-up is necessary to confirm the efficacy for patients with transitional cell carcinoma of the renal pelvis and ureter.
机译:目的:为评估我们新的腹腔镜后肾输尿管切除术对肾盂和输尿管移行细胞癌患者的疗效,我们提供了23例腹膜后镜的手术方法和临床结局分析。方法:2000年2月至2002年2月之间,对23例上尿路移行细胞癌患者进行了腹膜后腹腔镜肾切除术。患者年龄为44至83岁(平均66.7岁)。整个腹膜后解剖每个肾脏,连同肾周围脂肪组织,淋巴结和/或肾上腺,不横切输尿管。切除下输尿管,用超声刀和内窥镜胃肠自动吻合器切开膀胱袖口。通过6厘米长的原始切口完整切除解剖标本。结果:平均手术时间为4.8小时,包括用膀胱套完全切除输尿管末端的0.7小时。平均估计失血量为304毫升。恢复到正常活动的平均时间为18天。在平均15个月的随访期内,有2例患者在术后第六个月因癌症进展而死亡,2例因其他原因死亡,并且4例在术后复发了膀胱移行细胞癌。结论:我们采用内窥镜胃肠自动吻合器进行腹膜后腹腔镜肾结直肠切除术是一种快速,低风险,微创手术,可能是其他腹腔镜技术和开放性肾结直肠切除术的替代方法。但是,需要长期随访以确认对肾盂和输尿管移行细胞癌患者的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号